|
Dialight plc (the "Company")
Director / PDMR Shareholding
Options and Awards under the Dialight plc 2014 Performance Share Plan On 5 April 2023 the under-mentioned Directors / Persons Discharging Managerial Responsibility were each granted a nil cost option which entitled them to receive ordinary shares of 1.89 pence each in the Company in accordance with the rules of the Dialight PLC 2014 Performance Share Plan ("PSP").
On 5 April 2023 the under-mentioned Persons Discharging Managerial Responsibility, were granted a conditional award, which entitled them to acquire ordinary shares of 1.89 pence each at nil cost in the Company in accordance with the rules of the PSP.
Options and awards will normally vest on the third anniversary of grant subject to continued employment. No consideration was paid for the grant of these options and awards and no consideration is due to be paid by the participants on the vesting of these options and awards. On vesting, options will be exercisable between 5 April 2026 and 5 April 2028. In respect of Fariyal Khanbabi and Clive Jennings, a mandatory two-year post-vesting holding period applies to each award.
The notifications below, which have been made in accordance with the requirement of the UK Market Abuse Regulation provide further details.
Richard Allan General Counsel & Company Secretary DD: +44 (0) 203 058 3546
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
